Results from a novel experimental therapy for type 1 diabetes that boosts parts of the healthy immune system were reported today. The trial was led by Carla Greenbaum, MD, Diabetes Research Program at Benaroya Research Institute at Virginia Mason and sponsored by the Immune Tolerance Network.
Research on a unique vertebrate called the sea lamprey shows that more than a thousand genes are shed during its early development and “sealed’ into a compartment so they cannot be misexpressed and create untoward problems. The study was done at Benaroya Research Institute at Virginia Mason.
Benaroya Research Institute and Novo Nordisk collaborate on autoimmune disease research. Groundbreaking agreement aims to achieve better, faster diagnosis and treatment of rheumatoid arthritis, inflammatory bowel disease and lupus.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right